COLVIN PAUL 4
4 · Syneos Health, Inc. · Filed Mar 4, 2021
Insider Transaction Report
Form 4
COLVIN PAUL
Pres., Clinical Solutions
Transactions
- Award
Class A Common Stock
2021-03-02+1,629→ 29,904 total - Award
Class A Common Stock
2021-03-02+1,048→ 30,952 total
Footnotes (2)
- [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2020 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. determines the attainment level of the performance goals for the year ended December 31, 2021, subject to continued employment.
- [F2]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2020 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.